Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) this morning announced that, through a wholly owned U.S. subsidiary, it has finalized its investment into Applied Cannabis Sciences of New Jersey (“ACS”). The investment was previously announced in an April 15, 2019, press release as a letter of intent. According to the update, ACS will submit its application in the upcoming New Jersey round of Request for Applications (“RFA”), through which the state will issue 24 new permits comprising of 15 dispensary permits, 5 cultivation permits and 4 vertically integrated permits. “Completing this investment with ACS and being on the ground floor toward expanding New Jersey’s medical marijuana program marks a significant step forward in our Company’s East Coast expansion plans,” Chemistree President Karl Kottmeier said in the news release. “We expect, along with ACS’ leading cannabis experts and track record, that we will be able to secure this highly coveted and valuable State license.”
To view the full press release, visit http://cnw.fm/cU6Sc
About Chemistree Technology Inc.
Chemistree Technology Inc. is an investment company dedicated to the U.S. cannabis sector, endeavoring to provide turn-key solutions for the regulated cannabis industry. The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities. Outside of Washington State, Chemistree owns the exclusive worldwide rights to the Sugarleaf brand. For more information, visit www.Chemistree.ca
NOTE TO INVESTORS: The latest news and updates relating to CHMJF are available in the company’s newsroom at http://cnw.fm/CHMJF
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
